SNPHF (Santen Pharmaceutical Co) Inventories, Other: $405 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNPHF Santen Pharmaceutical Co Ltd SNPHF
72 GF Score
Price $13.05
GF Value $10.46
Valuation Modestly Overvalued
View Full Analysis

What is Santen Pharmaceutical Co Inventories, Other?

Santen Pharmaceutical Co SNPHF +4.40% 72 Inventories, Other is $405 Mil as of Jun. 2026. GuruFocus rates SNPHF with a GF Score™ of 72/100 and a GF Value™ of $10.46 (Modestly Overvalued).

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Santen Pharmaceutical Co's other inventories for the quarter that ended in Jun. 2026 was $405 Mil.

Santen Pharmaceutical Co's quarterly other inventories increased from Dec. 2025 ($385 Mil) to Mar. 2026 ($407 Mil) but then declined from Mar. 2026 ($407 Mil) to Jun. 2026 ($405 Mil).

Santen Pharmaceutical Co's annual other inventories increased from Mar. 2024 ($288 Mil) to Mar. 2025 ($346 Mil) and increased from Mar. 2025 ($346 Mil) to Mar. 2026 ($407 Mil).

Santen Pharmaceutical Co Inventories, Other Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Inventories, Other Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 313.22 294.41 288.25 346.11 407.00

Santen Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 410.06 400.93 385.28 407.00 404.75
SNPHF
72GF Score
Santen Pharmaceutical Co Ltd SNPHF
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $405 Mil mean?
Santen Pharmaceutical Co (SNPHF) has a Inventories, Other of $405 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Santen Pharmaceutical Co and its competitors.
Is Santen Pharmaceutical Co's Inventories, Other too high?
Santen Pharmaceutical Co's current Inventories, Other is $405 Mil. Overall, Santen Pharmaceutical Co has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Inventories, Other compare to LLY and JNJ?
Santen Pharmaceutical Co's Inventories, Other of $405 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Drug Manufacturers company?
A good Inventories, Other depends on the Drug Manufacturers industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Santen Pharmaceutical Co and its competitors. Santen Pharmaceutical Co's current Inventories, Other is $405 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Santen Pharmaceutical Co (SNPHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.46, compared to a current price of $13.05 — trading 24.8% above its estimated fair value. The current Inventories, Other is $405 Mil. Santen Pharmaceutical Co's overall GF Score™ is 72/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Santen Pharmaceutical Co (SNPHF), the current Inventories, Other is $405 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (SNPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of $13.05 is trading 24.8% above its estimated GF Value™ of $10.46. GuruFocus considers Santen Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SNPHF:

  • Inventories, Other: $405 Mil
  • GF Value™: $10.46 vs. price of $13.05 (24.8% above fair value)
  • GF Score™: 72/100

No single metric tells the full story. See the SNPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
72GF Score

Get the complete analysis for SNPHF

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.05
Price
$10.46
GF Value